Itci stock target
TGT (common stock). $96.35 Price. Stock is Up 3.78 Change. 793,708 Volume. Stock is Up 4.08% % Change. Intraday High; $96.48: Intraday Low; $92.13 TGT: Get the latest Target stock price and detailed information including TGT news, historical charts and realtime prices. ITCI Stock Price | Intra-Cellular Therapies Inc. Stock ... ITCI | Complete Intra-Cellular Therapies Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ITCI Stock Price, Forecast & News (Intra-Cellular Therapies)
23 Mar 2020 (ITCI) shares on Friday's trading session, jumped 5.05 percent to see the stock exchange hands at $13.52 per unit. Lets a quick look at company's
Mar 04, 2020 · On Tuesday, shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) marked $21.32 per share versus a previous $21.88 closing price. With having a -2.56% loss, an insight into the fundamental values of Intra-Cellular Therapies, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. Intra-Cellular Therapies Inc (NASDAQ:ITCI) Receives $33.14 ... One investment analyst has rated the stock with a sell rating, three have issued a hold rating and nine have given a buy rating to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $33.14. ITCI has been the topic of several analyst reports. Intra-Cellular Therapies: This Small Cap Biotech Will Not ... 11 hours ago · The average 12-month price target of all analysts covering the stock is $46, with $26 being the lowest and $70 being the highest. I think my $30 price target is realistic. ITCI is a solid bet Intra-cellular Therapies Inc. - ITCI - Stock Price Today ... View Intra-Cellular Therapies Inc. ITCI investment & stock information. Get the latest Intra-Cellular Therapies Inc. ITCI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Nov 06, 2019 · Intra-Cellular Therapies Inc. historial options data by MarketWatch. View ITCI option chain data and pricing information for given maturity periods. FedEx stock price target raised to $131
Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Intra- Cellular Therapies Inc have a median target of 37.00, with a high estimate of See Intra-Cellular Therapies price target based on 4 analysts offering 12 month price targets for Intra-Cellular Therapies in the last 3 months. The average price Find the latest Intra-Cellular Therapies Inc. (ITCI) stock quote, history, news and other vital information to help you with your stock trading 1y Target Est, 46.00 Intra-Cellular Therapies Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ITCI updated stock price target summary. ITCI. Real-time BATS EXCHANGE - 03/19 04:00:04 pm. 27.29USD. +121.69%. Consensus Loading Target Price consensus revisions : last 18 months. ITCI | Complete Intra-Cellular Therapies Inc. stock news by MarketWatch. View real-time Intra-Cellular Therapies stock price target raised to $65 vs. $29 at
Intra-Cellular Therapies (NASDAQ:ITCI) had its target price raised by Canaccord Genuity from $29.00 to $65.00 in a research note published on Monday morning, BenzingaRatingsTable reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. ITCI has been the topic of a number of other research reports.
ITCI -- Is Its Stock Price A Worthy Investment? Learn More. Intra-Cellular Therapies is developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases and diseases of the elderly, including Parkinson's and Alzheimer's disease. The company was founded in 2002 and is based in New York, New York. Intra-Cellular Therapies (NASDAQ:ITCI) Trading Ideas ...
Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Intra- Cellular Therapies Inc have a median target of 37.00, with a high estimate of
More Zacks News for ITCI. Other News for ITCI Interesting ITCI Put And Call Options For April 17th 03/09/20-9:46AM EST Stock Options Channel Intra-Cellular price target lowered to $68 from $73 at BTIG Is It Right Time to Be Cautious on Intra-Cellular ... Mar 17, 2020 · The stock was given Buy rating by Jefferies in its report released on August 12, 2019, the day when the price target on the stock was placed at 16. JP Morgan was of a view that ITCI is Overweight in its latest report on February 26, 2018. RBC Capital Mkts thinks that ITCI is worth Outperform rating. Intra-Cellular Therapies Inc. - NASDAQ:ITCI - Stock Quote ... View detailed financial information, real-time news, videos, quotes and analysis on Intra-Cellular Therapies Inc. (NASDAQ:ITCI). Explore commentary on Intra-Cellular Therapies Inc. and hear what Intra-Cellular Therapies - ITCI - Stock Price & News | The ...
See Intra-Cellular Therapies price target based on 4 analysts offering 12 month price targets for Intra-Cellular Therapies in the last 3 months. The average price Find the latest Intra-Cellular Therapies Inc. (ITCI) stock quote, history, news and other vital information to help you with your stock trading 1y Target Est, 46.00 Intra-Cellular Therapies Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ITCI updated stock price target summary. ITCI. Real-time BATS EXCHANGE - 03/19 04:00:04 pm. 27.29USD. +121.69%. Consensus Loading Target Price consensus revisions : last 18 months. ITCI | Complete Intra-Cellular Therapies Inc. stock news by MarketWatch. View real-time Intra-Cellular Therapies stock price target raised to $65 vs. $29 at